Related Experiment Video
Updated: Feb 16, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
Published on: October 28, 2014
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
Olatz Arrizabalaga1, Leire Moreno-Cugnon1, Jaione Auzmendi-Iriarte1
1Cellular oncology group, Biodonostia Health Research Institute, San Sebastian, Spain.
Abstract:
The elucidation of mechanisms involved in resistance to therapies is essential to improve the survival of patients with malignant gliomas. A major feature possessed by glioma cells that may aid their ability to survive therapy and reconstitute tumors is the capacity for self-renewal. We show here that glioma stem cells (GSCs) express low levels of MKP1, a dual-specificity phosphatase, which acts as a negative inhibitor of JNK, ERK1/2, and p38 MAPK, while induction of high levels of MKP1 expression are associated with differentiation of GSC. Notably, we find that high levels of MKP1 correlate with a subset of glioblastoma patients with better prognosis and overall increased survival. Gain of expression studies demonstrated that elevated MKP1 impairs self-renewal and induces differentiation of GSCs while reducing tumorigenesis in vivo. Moreover, we identified that MKP1 is epigenetically regulated and that it mediates the anti-tumor activity of histone deacetylase inhibitors (HDACIs) alone or in combination with temozolomide. In summary, this study identifies MKP1 as a key modulator of the interplay between GSC self-renewal and differentiation and provides evidence that the activation of MKP1, through epigenetic regulation, might be a novel therapeutic strategy to overcome therapy resistance in glioblastoma.
Insights
This study reveals that activating MKP1 in glioma stem cells (GSCs) inhibits their self-renewal and promotes differentiation, offering a new strategy against glioblastoma therapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Biology
Background:
- Malignant gliomas, particularly glioblastoma, exhibit resistance to therapy, partly due to the self-renewal capacity of glioma stem cells (GSCs).
- Understanding the molecular mechanisms governing GSC self-renewal and differentiation is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of MKP1 (a dual-specificity phosphatase) in regulating GSC self-renewal and differentiation.
- To explore MKP1's potential as a therapeutic target for overcoming glioblastoma therapy resistance.
Main Methods:
- Analysis of MKP1 expression levels in GSCs and correlation with patient prognosis.
- Gain-of-expression studies to assess the impact of elevated MKP1 on GSC self-renewal, differentiation, and tumorigenesis.
- Investigation of the epigenetic regulation of MKP1 and its role in mediating the effects of histone deacetylase inhibitors (HDACIs).
Main Results:
- GSCs express low levels of MKP1, which inhibits JNK, ERK1/2, and p38 MAPK pathways.
- High MKP1 expression is associated with GSC differentiation and correlates with better prognosis and survival in glioblastoma patients.
- Elevated MKP1 impairs GSC self-renewal, reduces tumorigenesis in vivo, and mediates the anti-tumor effects of HDACIs.
Conclusions:
- MKP1 is a key regulator of the balance between GSC self-renewal and differentiation.
- Epigenetic activation of MKP1 represents a potential novel therapeutic strategy to enhance treatment efficacy and overcome therapy resistance in glioblastoma.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
09:31Inducible, Cell Type-Specific Expression in Arabidopsis thaliana Through LhGR-Mediated Trans-Activation
Published on: April 19, 2019
Related Concept Videos
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Cell Specific Gene Expression
Induced Pluripotent Stem Cells
Adult Stem Cells